Whole genome sequencing prioritizes CHEK2, EWSR1, and TIAM1 as possible predisposition genes for familial non-medullary thyroid cancer

Familial inheritance in non-medullary thyroid cancer (NMTC) is an area that has yet to be adequately explored. Despite evidence suggesting strong familial clustering of non-syndromic NMTC, known variants still account for a very small percentage of the genetic burden. In a recent whole genome sequen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Srivastava, Aayushi (VerfasserIn) , Giangiobbe, Sara (VerfasserIn) , Skopelitou, Diamanto (VerfasserIn) , Miao, Beiping (VerfasserIn) , Paramasivam, Nagarajan (VerfasserIn) , Diquigiovanni, Chiara (VerfasserIn) , Bonora, Elena (VerfasserIn) , Hemminki, Kari (VerfasserIn) , Försti, Asta (VerfasserIn) , Bandapalli, Obul Reddy (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 22 February 2021
In: Frontiers in endocrinology
Year: 2021, Jahrgang: 12, Pages: 1-10
ISSN:1664-2392
DOI:10.3389/fendo.2021.600682
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3389/fendo.2021.600682
Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/article/10.3389/fendo.2021.600682
Volltext
Verfasserangaben:Aayushi Srivastava, Sara Giangiobbe, Diamanto Skopelitou, Beiping Miao, Nagarajan Paramasivam, Chiara Diquigiovanni, Elena Bonora, Kari Hemminki, Asta Försti, Obul Reddy Bandapalli

MARC

LEADER 00000caa a2200000 c 4500
001 1776353250
003 DE-627
005 20240414193544.0
007 cr uuu---uuuuu
008 211108s2021 xx |||||o 00| ||eng c
024 7 |a 10.3389/fendo.2021.600682  |2 doi 
035 |a (DE-627)1776353250 
035 |a (DE-599)KXP1776353250 
035 |a (OCoLC)1341423309 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Srivastava, Aayushi  |d 1997-  |e VerfasserIn  |0 (DE-588)1205029583  |0 (DE-627)1690362073  |4 aut 
245 1 0 |a Whole genome sequencing prioritizes CHEK2, EWSR1, and TIAM1 as possible predisposition genes for familial non-medullary thyroid cancer  |c Aayushi Srivastava, Sara Giangiobbe, Diamanto Skopelitou, Beiping Miao, Nagarajan Paramasivam, Chiara Diquigiovanni, Elena Bonora, Kari Hemminki, Asta Försti, Obul Reddy Bandapalli 
264 1 |c 22 February 2021 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.11.2021 
520 |a Familial inheritance in non-medullary thyroid cancer (NMTC) is an area that has yet to be adequately explored. Despite evidence suggesting strong familial clustering of non-syndromic NMTC, known variants still account for a very small percentage of the genetic burden. In a recent whole genome sequencing (WGS) study of five families with several NMTCs, we shortlisted promising variants with the help of our in-house developed Familial Cancer Variant Prioritization Pipeline (FCVPPv2). Here, we report potentially disease-causing variants in checkpoint kinase 2 (CHEK2), Ewing sarcoma breakpoint region 1 (EWSR1) and T-lymphoma invasion and metastasis-inducing protein 1 (TIAM1) in one family. Performing WGS on three cases, one probable case and one healthy individual in a family with familial NMTC left us with 112254 variants with a minor allele frequency of less than 0.1%, which was reduced by pedigree-based filtering to 6368. Application of the pipeline led to the prioritization of seven coding and nine non-coding variants from this family. The variant identified in CHEK2, a known tumor suppressor gene involved in DNA damage-induced DNA repair, cell cycle arrest, and apoptosis, has been previously identified as a germline variant in breast and prostate cancer and has been functionally validated by Roeb et al. in a yeast-based assay to have an intermediate effect on protein function. We thus hypothesized that this family may harbor additional disease-causing variants in other functionally related genes. We evaluated two further variants in EWSR1 and TIAM1 with promising in silico results and reported interaction in the DNA-damage repair pathway. Hence, we propose a polygenic mode of inheritance in this family. As familial NMTC is considered to be more aggressive than its sporadic counterpart, it is important to identify such susceptibility genes and their associated pathways. In this way, the advancement of personalized medicine in NMTC patients can be fostered. We also wish to reopen the discussion on monogenic vs polygenic inheritance in NMTC and instigate further development in this area of research. 
700 1 |a Giangiobbe, Sara  |e VerfasserIn  |0 (DE-588)1205815619  |0 (DE-627)1691512397  |4 aut 
700 1 |a Skopelitou, Diamanto  |e VerfasserIn  |0 (DE-588)1234066254  |0 (DE-627)1758740485  |4 aut 
700 1 |a Miao, Beiping  |e VerfasserIn  |0 (DE-588)1199379204  |0 (DE-627)1681667614  |4 aut 
700 1 |a Paramasivam, Nagarajan  |d 1985-  |e VerfasserIn  |0 (DE-588)1027462979  |0 (DE-627)729165485  |0 (DE-576)373239238  |4 aut 
700 1 |a Diquigiovanni, Chiara  |e VerfasserIn  |4 aut 
700 1 |a Bonora, Elena  |d 1960-  |e VerfasserIn  |0 (DE-588)1044878320  |0 (DE-627)77301179X  |0 (DE-576)398173486  |4 aut 
700 1 |a Hemminki, Kari  |d 1947-  |e VerfasserIn  |0 (DE-588)1150735872  |0 (DE-627)1010964402  |0 (DE-576)172043751  |4 aut 
700 1 |a Försti, Asta  |e VerfasserIn  |0 (DE-588)1155331672  |0 (DE-627)1017045755  |0 (DE-576)501623833  |4 aut 
700 1 |a Bandapalli, Obul Reddy  |d 1977-  |e VerfasserIn  |0 (DE-588)13397121X  |0 (DE-627)559235070  |0 (DE-576)30022544X  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in endocrinology  |d Lausanne : Frontiers Research Foundation, 2010  |g 12(2021) vom: 22. Feb., Artikel-ID 600682, Seite 1-10  |h Online-Ressource  |w (DE-627)645090948  |w (DE-600)2592084-4  |w (DE-576)336962975  |x 1664-2392  |7 nnas  |a Whole genome sequencing prioritizes CHEK2, EWSR1, and TIAM1 as possible predisposition genes for familial non-medullary thyroid cancer 
773 1 8 |g volume:12  |g year:2021  |g day:22  |g month:02  |g elocationid:600682  |g pages:1-10  |g extent:10  |a Whole genome sequencing prioritizes CHEK2, EWSR1, and TIAM1 as possible predisposition genes for familial non-medullary thyroid cancer 
856 4 0 |u https://doi.org/10.3389/fendo.2021.600682  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/article/10.3389/fendo.2021.600682  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211108 
993 |a Article 
994 |a 2021 
998 |g 13397121X  |a Bandapalli, Obul Reddy  |m 13397121X:Bandapalli, Obul Reddy  |d 50000  |e 50000PB13397121X  |k 0/50000/  |p 10  |y j 
998 |g 1155331672  |a Försti, Asta  |m 1155331672:Försti, Asta  |d 50000  |e 50000PF1155331672  |k 0/50000/  |p 9 
998 |g 1150735872  |a Hemminki, Kari  |m 1150735872:Hemminki, Kari  |d 50000  |e 50000PH1150735872  |k 0/50000/  |p 8 
998 |g 1027462979  |a Paramasivam, Nagarajan  |m 1027462979:Paramasivam, Nagarajan  |p 5 
998 |g 1199379204  |a Miao, Beiping  |m 1199379204:Miao, Beiping  |p 4 
998 |g 1234066254  |a Skopelitou, Diamanto  |m 1234066254:Skopelitou, Diamanto  |d 50000  |e 50000PS1234066254  |k 0/50000/  |p 3 
998 |g 1205815619  |a Giangiobbe, Sara  |m 1205815619:Giangiobbe, Sara  |p 2 
998 |g 1205029583  |a Srivastava, Aayushi  |m 1205029583:Srivastava, Aayushi  |d 50000  |e 50000PS1205029583  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1776353250  |e 3999732407 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 08.11.2021"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1776353250","language":["eng"],"person":[{"display":"Srivastava, Aayushi","roleDisplay":"VerfasserIn","role":"aut","family":"Srivastava","given":"Aayushi"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Giangiobbe, Sara","given":"Sara","family":"Giangiobbe"},{"roleDisplay":"VerfasserIn","display":"Skopelitou, Diamanto","role":"aut","family":"Skopelitou","given":"Diamanto"},{"role":"aut","display":"Miao, Beiping","roleDisplay":"VerfasserIn","given":"Beiping","family":"Miao"},{"role":"aut","display":"Paramasivam, Nagarajan","roleDisplay":"VerfasserIn","given":"Nagarajan","family":"Paramasivam"},{"family":"Diquigiovanni","given":"Chiara","display":"Diquigiovanni, Chiara","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Bonora, Elena","roleDisplay":"VerfasserIn","given":"Elena","family":"Bonora"},{"role":"aut","display":"Hemminki, Kari","roleDisplay":"VerfasserIn","given":"Kari","family":"Hemminki"},{"display":"Försti, Asta","roleDisplay":"VerfasserIn","role":"aut","family":"Försti","given":"Asta"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Bandapalli, Obul Reddy","given":"Obul Reddy","family":"Bandapalli"}],"title":[{"title":"Whole genome sequencing prioritizes CHEK2, EWSR1, and TIAM1 as possible predisposition genes for familial non-medullary thyroid cancer","title_sort":"Whole genome sequencing prioritizes CHEK2, EWSR1, and TIAM1 as possible predisposition genes for familial non-medullary thyroid cancer"}],"physDesc":[{"extent":"10 S."}],"relHost":[{"titleAlt":[{"title":"Bone Research"},{"title":"Cancer Endocrinology"},{"title":"Cellular Endocrinology"},{"title":"Diabetes"},{"title":"Endocrinology of Aging"},{"title":"Experimental Endocrinology"},{"title":"Genomic Endocrinology"},{"title":"Molecular and Structural Endocrinology"},{"title":"Neuroendocrine Science"},{"title":"Pediatric Endocrinology"},{"title":"Pituitary Endocrinology"},{"title":"Systems and Translational Endocrinology"},{"title":"Thyroid Endocrinology"}],"part":{"extent":"10","volume":"12","text":"12(2021) vom: 22. Feb., Artikel-ID 600682, Seite 1-10","pages":"1-10","year":"2021"},"pubHistory":["1.2010 -"],"language":["eng"],"recId":"645090948","note":["Gesehen am 12.12.19","Specialty sections: Bone Research; Cancer Endocrinology; Cellular Endocrinology; Diabetes; Endocrinology of Aging; Experimental Endocrinology; Genomic Endocrinology; Molecular and Structural Endocrinology; Neuroendocrine Science; Pediatric Endocrinology; Pituitary Endocrinology; Systems and Translational Endocrinology; Thyroid Endocrinology"],"disp":"Whole genome sequencing prioritizes CHEK2, EWSR1, and TIAM1 as possible predisposition genes for familial non-medullary thyroid cancerFrontiers in endocrinology","type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title_sort":"Frontiers in endocrinology","title":"Frontiers in endocrinology"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1664-2392"],"eki":["645090948"],"zdb":["2592084-4"]},"origin":[{"publisherPlace":"Lausanne","dateIssuedDisp":"2010-","publisher":"Frontiers Research Foundation","dateIssuedKey":"2010"}]}],"name":{"displayForm":["Aayushi Srivastava, Sara Giangiobbe, Diamanto Skopelitou, Beiping Miao, Nagarajan Paramasivam, Chiara Diquigiovanni, Elena Bonora, Kari Hemminki, Asta Försti, Obul Reddy Bandapalli"]},"origin":[{"dateIssuedDisp":"22 February 2021","dateIssuedKey":"2021"}],"id":{"doi":["10.3389/fendo.2021.600682"],"eki":["1776353250"]}} 
SRT |a SRIVASTAVAWHOLEGENOM2220